It is vital to have a close look at Applied DNA Sciences Inc. (NASDAQ:APDN) to get a clear picture of the company and where it stands currently. The analysis will also help to assess what it offers for prospective investors. For the purpose, we will do a fundamental evaluation of the stock.
Last quarter, the company recorded sales of $905,373 in total revenues. That exhibits an overall change in sales, on a quarterly year/year basis, of 0.37%. If we change that into sequential terms, the firm saw sales grow by 0% from quarter to quarter.
Applied DNA Sciences Inc. (NASDAQ: APDN) is intriguing when studied as per its core data. The cost of selling goods in previous quarter was $460,740, recording a gross basic income of $444,633. For shareholders, provided the total diluted outstanding shares of 26.35M, this means an overall EPS of $(0.13). Note, this equates with a consensus analyst projection of $0.00 in earnings per share for its imminent fiscal quarterly report.
Analysts have a consensus average recommendation of Buy grounded on a total of 1 analysts? ratings.
As far as price targets, street analysts currently gave an average target on equities of at $6.00. In addition, if looked to next year, the estimates of a fiscal year projection to bring about 0.01 in total earnings per share. Also, on a median price to earnings ratio basis, that view adds up to an estimation of N/A times earnings.
As the reader is aware, for any entity, balance sheet vigor sits at the heart of the firm’s capacity to stand up to the obligations and demands incurred by contingent and normal operations, which in turn lies at the company’ core to retain the faith of shareholders in the marketplace. For Applied DNA Sciences Inc. (NASDAQ:APDN), the firm presently holds about $4.02M in cash in the coffers compared to $- in total current liabilities.
The company’s debt has been $falling. Total assets stands at $13.22M balanced by $3.93M in total liabilities, which implies where this story might go under grave economic or financial conditions.
The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction. Longer term, the trend strength is Strong.
As far as cash flows, the company posted a free cash flow past quarter of $(2.68M), exhibiting a quarterly net change of $(2.68M). On a net operating level, the cash flow was around $(2.63M).
We will update the exciting story of Applied DNA Sciences Inc. (NASDAQ:APDN) as new events transpire.
